Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 22, 2015, 41 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $39.80 to $4,886,077.92.

Highlighted Stocks Traded by Insiders:

Vical (VICL) - FREE Research Report

Ramos Anthony Alan, who is VP, Chief Accounting Officer at Vical, sold 428 shares at $1.09 on Jan. 22, 2015. Following this transaction, the VP, Chief Accounting Officer owned 147,508 shares meaning that the stake was reduced by 0.29% with the 428-share transaction.

The shares most recently traded at $1.04, down $0.05, or 4.81% since the insider transaction. Historical insider transactions for Vical go as follows:

  • 4-Week # shares bought: 564,494
  • 4-Week # shares sold: 7,984
  • 12-Week # shares bought: 564,494
  • 12-Week # shares sold: 7,984
  • 24-Week # shares bought: 564,494
  • 24-Week # shares sold: 53,897

The average volume for Vical has been 420,100 shares per day over the past 30 days. Vical has a market cap of $94.8 million and is part of the health care sector and drugs industry. Shares are down 1.9% year-to-date as of the close of trading on Thursday.

Vical Incorporated is engaged in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Currently, there is 1 analyst who rates Vical a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on VICL - FREE

TheStreet Quant Ratings

Scroll to Continue

TheStreet Recommends

rates Vical as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full

Vical Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Argan (AGX) - FREE Research Report

Trudel Arthur F, who is Former Senior VP and CFO at Argan, sold 10,000 shares at $30.60 on Jan. 22, 2015. Following this transaction, the Former Senior VP and CFO owned 10,000 shares meaning that the stake was reduced by 50% with the 10,000-share transaction.

The shares most recently traded at $31.60, up $1.00, or 3.18% since the insider transaction. Historical insider transactions for Argan go as follows:

  • 4-Week # shares sold: 22,861
  • 12-Week # shares bought: 1,400
  • 12-Week # shares sold: 42,181
  • 24-Week # shares bought: 1,400
  • 24-Week # shares sold: 62,181

The average volume for Argan has been 88,700 shares per day over the past 30 days. Argan has a market cap of $443.1 million and is part of the industrial goods sector and materials & construction industry. Shares are down 5.41% year-to-date as of the close of trading on Thursday.

Argan, Inc. developments, builds, operates, and maintains public and independent power generation utilities as well as providing telecommunications infrastructure services. The company has a P/E ratio of 13.4. Currently, there are no analysts who rate Argan a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AGX - FREE

TheStreet Quant Ratings

rates Argan as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, growth in earnings per share and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Argan Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Guidance Software (GUID) - FREE Research Report

Van der Colff Rasmus, who is CAO/ VP of Finance at Guidance Software, sold 4,300 shares at $6.96 on Jan. 22, 2015. Following this transaction, the CAO/ VP of Finance owned 63,862 shares meaning that the stake was reduced by 6.31% with the 4,300-share transaction.

The shares most recently traded at $6.78, down $0.18, or 2.65% since the insider transaction. Historical insider transactions for Guidance Software go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 10,000

The average volume for Guidance Software has been 94,700 shares per day over the past 30 days. Guidance Software has a market cap of $202.2 million and is part of the technology sector and computer software & services industry. Shares are down 4.97% year-to-date as of the close of trading on Thursday.

Guidance Software, Inc. provides digital investigative solutions in the United States, Europe, Asia, and internationally. Currently, there are 2 analysts who rate Guidance Software a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GUID - FREE

TheStreet Quant Ratings

rates Guidance Software as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Guidance Software Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null